ACUTE CHANGES IN PLASMA NONESTERIFIED FATTY-ACID CONCENTRATION DO NOT CHANGE HEPATIC GLUCOSE-PRODUCTION IN PEOPLE WITH TYPE-2 DIABETES

被引:17
作者
JOHNSTON, P [1 ]
HOLLENBECK, C [1 ]
SHEU, W [1 ]
CHEN, YDI [1 ]
REAVEN, GM [1 ]
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,STANFORD,CA 94305
关键词
Glucose disposal rate; Hepatic glucose production; Lipid infusion; Nicotinic acid; Non‐esterified fatty acid; Plasma glucose concentration; Type; 2; diabetes;
D O I
10.1111/j.1464-5491.1990.tb01321.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of changes in plasma non‐esterified fatty acid concentration (NEFA) on plasma glucose concentration, hepatic glucose production (Ra), and glucose disposal (Rd) rates was determined in 14 patients with Type 2 diabetes. Seven patients had relatively mild fasting hyperglycaemia (< 10.0 mmol l−1), whereas the remaining seven had relatively severe fasting hyperglycaemia (> 14.0 mmol l−1). Each patient was infused from 2000 to 0800 h with 3‐3H‐glucose on two occasions, with or without neutral fat emulsion and heparin (mild hyperglycaemia group), or with or without nicotinic acid (severe hyperglycaemia group). Plasma NEFA concentration increased from 0.33 ± 0.06 (± SE) to 4.78 ± 0.42 mmol l−1 in response to the lipid and heparin infusion, but plasma glucose concentration (7.8 ± 0.7 vs 7.4 ± 0.8 mmol l−1), Ra (0.44 ± 0.02 vs 0.46 ± 0.02 mmol m−2 min−1), and Rd (0.42 ± 0.02 vs 0.46 ± 0.02 mmol m−2 min−1) were unchanged. Nicotinic acid decreased plasma NEFA concentration from 0.54 ± 0.15 to 0.23 ± 0.08 mmol l−1, but plasma glucose (15.0 ± 1.0 vs 15.5 ± 1.4 mmol l−1), Ra (0.74 ± 0.07 vs 0.68 ± 0.07 mmol m−2 min−1), and Rd (0.73 ± 0.07 vs 0.68 ± 0.07 mmol m−2 min−1) were unchanged. The results indicate that acute changes in plasma NEFA concentration did not lead to any change in overnight glucose production or disposal rates. 1990 Diabetes UK
引用
收藏
页码:871 / 875
页数:5
相关论文
共 17 条
  • [1] Fraze E., Donner CC, Swislocki ALM, Chian Y-AM, Chen Y-DI, Reaven GM, Ambient plasma free fatty acid concentration in NIDDM: Evidence for insulin resistance, J Clin Endocrinol Metab, 61, pp. 807-811, (1985)
  • [2] Golay A., Chen Y-DI, Reaven GM, Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and FFA metabolism in obese individuals, J Clin Endocrinol Metab, 62, pp. 1081-1088, (1986)
  • [3] Chen Y-DI, Golay A., Swislocki ALM, Reaven GM, Resistance to insulin suppression of plasma FFA concentration and insulin stimulation of glucose uptake in NIDDM, J Clin Endocrinol Metab, 64, pp. 17-21, (1987)
  • [4] Golay A., Swislocki ALM, Chen Y-DI, Reaven GM, Relationship between plasma FFA concentration, endogenous glucose production, and fasting hyperglycemia in normal and NIDDM individuals, Metabolism, 36, pp. 692-696, (1987)
  • [5] Reaven GM, Role of insulin resistance in human disease, Diabetes, 37, pp. 1595-1607, (1988)
  • [6] Reaven GM, Chang H., Ho H., Jeng C-Y, Hoffman BB, Lowering of plasma glucose in diabetic rats by antilipolytic agents, Am J Physiol, 254, (1988)
  • [7] Reaven GM, Chang H., Hoffman BB, Additive hypoglycemic effects of drugs that modify free fatty acid metabolism by different mechanisms in rats with streptozocin‐induced diabetes, Diabetes, 37, pp. 28-32, (1988)
  • [8] Shimizu S., Yasui K., Taui Y., Yamada H., Acyl‐CoA oxidase from Candida tropicalis, Biochem Biophys Res Commun, 91, pp. 108-113, (1979)
  • [9] Kadish AH, Litle RL, Sternberg JC, A new and rapid method for determination of glucose by measurement of rate of oxygen consumption, Clin Chem, 14, pp. 116-131, (1968)
  • [10] Hales CN, Randle PJ, Immunoassay of insulin with insulin‐antibody precipitate, Biochem J, 88, pp. 137-146, (1963)